Irina A. Gorbacheva

Irina A. Gorbacheva

Auto-generated profile, based on publicly available information

Irina A. Gorbacheva

Pavlov University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Minerva Gastroenterologica E Dietologica
Verified
Journal Article
Closed access
VIVladimir Ivashkin
Vladimir Ivashkin
MMMarina V. Maevskaya
Marina V. Maevskaya
ZKZhanna D. Kobalava
Zhanna D. Kobalava
YUYuriy P. Uspenskiy
Yuriy P. Uspenskiy
JFJulia A. Fominih
Julia A. Fominih
SSSuntje Sander-Struckmeier
Suntje Sander-Struckmeier
The effect of oral and/or parenteral ademetionine (500 mg intravenous [IV] and tablet formulation) on clinical symptoms and biochemical markers of intrahepatic cholestasis (IHC) was investigated in subjects with alcoholic liver disease (ALD) and compensated liver function. Prospective, multicenter, open-label study consisting of a screening period and an 8-week treatment period and performed in subjects (18-75 years) with compensated ALD and confirmed IHC. Subjects with a baseline serum conjugated bilirubin value above normal range were initially treated with IV ademetionine for two weeks (500-800 mg daily) and continued with oral ademetionine 1500 mg daily for a further six weeks. Subjects with a baseline serum conjugated bilirubin value within normal range were treated with oral ademetionine for eight weeks. A total of 72 subjects were treated; 41 initially with IV ademetionine and 31 with oral ademetionine. Clinical symptoms status improved from baseline to end of treatment with an increase in the proportion of subjects with no symptoms. Ademetionine showed significant improvements in primary efficacy parameters alkaline phosphatase (ALP) and γ-glutamyltransferase (γGT) (P<0.0001). Although decreases of ALP were higher for subjects initially treated with IV ademetionine, these subjects also had higher baseline values. No safety concerns with ademetionine arose with respect to the severity or frequency of adverse events (AEs) during the treatment period, laboratory parameters, and vital signs. Administration of oral or IV/oral ademetionine step-therapy for 8 weeks to subjects with IHC due to ALD was safe and provided a significant improvement of disease burden.

1 January 2021 in Russian Otorhinolaryngology
Verified
Journal Article
Closed access
ASA. V. Shabrov
A. V. Shabrov
IGI. A. Gorbacheva
I. A. Gorbacheva
YFYu. A. Fominykh
Yu. A. Fominykh
YSYu. A. Sycheva
Yu. A. Sycheva
ODO. S. Donskaya
O. S. Donskaya
IKI. V. Koshel’
I. V. Koshel’
The search for common links of etiology and pathogenesis in the formation of comorbid pathology in modern patients opens up additional opportunities for increasing the effectiveness of their treatment and is an important problem in scientific and practical medicine. The extreme prevalence of chronic persistence of immunotropic viruses, such as herpes genotypes 4,5,6 types, requires a study of its consequences in the human body and the involvement in its infectious-dependent morbidity, such as the formation of multiple chronic foci of infection in the ear, nose and throat with frequent and prolonged exacerbations. The work shows that chronic sinusitis, nasopharyngitis, tonsillitis associated with chronic herpesvirus persistence form the status of frequently and long-term ill people against the background of pronounced immuno-compromise with quantitative and functional T- and B-cell deficiency, insufficient resources of α and γ- interferon. The study presents a positive experience of replenishing the deficiency of α and γ-interferons with recombinant drugs of the same name in comorbid ENT patients. The aim of the study was to increase the efficiency of treatment of patients with concomitant chronic focal infection in the ear, nose and throat against the background of chronic persistence of herpesvirus infection. Materials and methods: Comprehensive clinical and laboratory examination of 45 carriers of herpes simplex virus genotypes 4,5, 6 at the age of 29 to 52 years made it possible to establish in them a comorbid chronic focal infection in the LOR organs: chronic sinusitis, chronic nasopharyngitis, chronic tonsillitis. Results: The observed patients had a statistically significant (p < 0.01) deficiency of NK cells with receptors CD16+, CD56+ and B cells with markers CD19+, CD5+ against the background of peripheral blood lymphocytosis with an increase in the content of cytotoxic T lymphocytes (CD8 +) marker in some patients. All patients showed a significant decrease in interferon system resources (p < 0.01). Replacement therapy with recombinant preparations of α- and γ-interferons led to restoration of interferon system parameters and was accompanied by improvement of immunological blood indices, both quantitative and functional characteristics of T-and B-lymphocytes, mononuclear phagocytes, this dynamics was matched by improvement of patients, confirmed by results of questionnaire. Conclusions: Thus, the positive experience of antiviral therapy by restoring the resources of the interferon system and immune recovery with recombinant interferon drugs indicates the important role of herpes virus carrier in the formation of comorbidity and the need for etiological treatment to improve the condition and quality of life of patients.

21 February 2019 in Translational Medicine
Verified
Journal Article
Open access
PDF file
YUYu. P. Uspenskiy
Yu. P. Uspenskiy
IGI. A. Gorbacheva
I. A. Gorbacheva
SASuvorov N Alexander
Suvorov N Alexander
MGMichael Galagudza
Michael Galagudza
NBNataia V Baryshnikova
Nataia V Baryshnikova
ЮУЮ. П. Успенский
Ю. П. Успенский
In this article we wrote about main immunologic disorders in Helicobacter pylori infected patients (changes of local, cell and humoral immunity). We have our own data about changes of interleukins 1β, 4 and 8 level in cagA(+) and cagA(−) Helicobacter pylori strains infected patients: we saw that level of proinflammatory interleukin-1β and unterleukin-8 are higher and level of anti-inflammatory interleukin-4 are lower in patients infected cagA(+) strains of Helicobacter pylori. We demonstrated results of different studies about efficacy of anti-Helicobacter pylori vaccines as immunologic prophylaxis of this microorganism invasion: usage of mucosal adjuvants and usage of immunostimulating probiotics during vaccination have promising results.

1 January 2021 in Russian Otorhinolaryngology
Verified
Journal Article
Open access
IGI. A. Gorbacheva
I. A. Gorbacheva
ODO. S. Donskaya
O. S. Donskaya
DPD. A. Popov
D. A. Popov
YSYu. A. Sycheva
Yu. A. Sycheva
YOYa. E. Osintseva
Ya. E. Osintseva
ERE. S. Ryazantseva
E. S. Ryazantseva
Архив медицинского научно-практического журнала «Российская оториноларингология»

1 January 2022 in Russian Otorhinolaryngology
Verified
Journal Article
Closed access
IGI. A. Gorbacheva
I. A. Gorbacheva
IAI. N. Antonova
I. N. Antonova
YSYu. A. Sycheva
Yu. A. Sycheva
YOYa. E. Osintseva
Ya. E. Osintseva
ODO. S. Donskaya
O. S. Donskaya
SHSaint Petersburg St. Luke Clinical Hospital
Saint Petersburg St. Luke Clinical Hospital
The high level of morbidity and labor losses among the population during the epidemic of a new coronavirus infection is largely determined by the protracted course of the post-COVID syndrome, which is often complicated by the exacerbation of chronic foci of infection of the upper respiratory tract and oral cavity. Clinical manifestations of a developed immunodeficiency state require an assessment of the characteristics of the body’s immunoreactivity in patients who have undergone COVID-19 in order to develop targeted programs for their immunorehabilitation and prevent manifestations of chronic focal infection, which was the purpose of the study. Immunological examination of 37 patients aged 42 to 60 years (53 ± 3.8 years), 24 women and 13 men, in the post-COVID period with exacerbation of chronic ENT infection (nasopharyngitis, sinusitis, otitis media, laryngitis) and dental pathology (generalized inflammatory periodontal disease, apical granulomas) showed the formation of an immunological imbalance with a quantitative deficiency of T-helpers with a high level of cytotoxic T-lymphocytes and NK cells expressing the alpha chain of the CD8 antigen as well as cytokine-producing NK cells against the background of a pronounced decrease in the resources of alpha and gamma interferon and a high level of Ig E and CIC in the blood. The established immunological prerequisites for comorbid infection, allergization, autoimmunization, and chronic sequel of inflammatory response motivated approaches to the rehabilitation of patients in the post-COVID period and the prevention of activation of chronic foci of infection in the ENT organs and oral cavity through sequential detoxification and immunocorrection. The positive experience of using bioactive preparations of natural origin with a complex detoxifying, immunotropic, antioxidant, and adaptogenic action is presented.

21 March 2020 in The Scientific Notes of the Pavlov University
Verified
Journal Article
Open access
PDF file
IAI. N. Antonova
I. N. Antonova
SVS. V. Vasil’eV
S. V. Vasil’eV
IGI. A. Gorbacheva
I. A. Gorbacheva
LOL. Yu. Orekhova
L. Yu. Orekhova
TTT. B. Tkachenko
T. B. Tkachenko
ЛОЛюдмила Юрьевна Орехова
Людмила Юрьевна Орехова
60th anniversary of the Faculty of Dentistry of Pavlov University.